NasdaqGM - Nasdaq Real Time Price USD
AtriCure, Inc. (ATRC)
32.30
+0.05
+(0.16%)
At close: May 15 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | -0.16 | -0.15 | -0.51 | -0.37 |
| Low Estimate | -0.19 | -0.17 | -0.53 | -0.46 |
| High Estimate | -0.14 | -0.12 | -0.49 | -0.28 |
| Year Ago EPS | -0.17 | -0.17 | -0.67 | -0.51 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | 130.17M | 129.51M | 522.9M | 588.9M |
| Low Estimate | 129.5M | 128.2M | 521.9M | 575.9M |
| High Estimate | 131.28M | 130.64M | 525.08M | 599.67M |
| Year Ago Sales | 116.27M | 115.91M | 465.31M | 522.9M |
| Sales Growth (year/est) | 11.96% | 11.74% | 12.38% | 12.62% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.17 | -0.2 | -0.15 | -0.22 |
| EPS Actual | -0.17 | -0.17 | -0.08 | -0.14 |
| Difference | 0 | 0.03 | 0.07 | 0.08 |
| Surprise % | 0.23% | 13.44% | 46.22% | 37.32% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.16 | -0.15 | -0.51 | -0.37 |
| 7 Days Ago | -0.16 | -0.15 | -0.51 | -0.37 |
| 30 Days Ago | -0.15 | -0.15 | -0.58 | -0.4 |
| 60 Days Ago | -0.15 | -0.15 | -0.58 | -0.35 |
| 90 Days Ago | -0.15 | -0.15 | -0.59 | -0.43 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 3 | 6 | 3 |
| Up Last 30 Days | 1 | 3 | 6 | 3 |
| Down Last 7 Days | 4 | 1 | -- | 2 |
| Down Last 30 Days | 4 | 1 | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATRC | 4.31% | 14.14% | 23.94% | 27.98% |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/30/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 4/30/2025 |
| Maintains | Needham: Buy to Buy | 4/30/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 4/2/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 3/28/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/27/2025 |
Related Tickers
ANGO AngioDynamics, Inc.
9.17
-1.29%
AVTR.VI Avantor, Inc.
11.60
-2.52%
ICUI ICU Medical, Inc.
140.54
+3.39%
BLFS BioLife Solutions, Inc.
21.99
-0.27%
AZTA Azenta, Inc.
26.71
-0.85%
NVST Envista Holdings Corporation
18.09
+0.89%
SRT3.DE Sartorius Aktiengesellschaft
229.40
0.00%
PLSE Pulse Biosciences, Inc.
16.49
+1.17%
LMAT LeMaitre Vascular, Inc.
83.30
+0.60%
AVR Anteris Technologies Global Corp.
3.9700
-3.17%